Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions

Journal of Virology

Volumn 73, Issue 7, 1999, Pages 5945-5956

  Young, John K ^a,c   Li, Donghui ^b   Abramowitz, Matthew C ^b   Morrison, Trudy G ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Center for Language and Brain   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HR1 PEPTIDE; HYBRID PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIRD DISEASE; CONTROLLED STUDY; ENZYME ACTIVATION; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS;

EID: 0033064154     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.7.5945-5956.1999     Document Type: Article

References (56)

1. Almeida, F. C. L., and S. J. Opella. 1993. fd coat protein structure in membrane environments: structural dynamics of the loop between the hydrophobic transmembrane helix and the amphipathic in-plane helix. J. Mol. Biol. 270:481-495.
2. Bagai, S., and R. A. Lamb. 1995. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 69:6712-6719.
3. Bax, A., and D. G. Davis. 1985. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65:355-360.
4. Buckland, R., E. Malvoisin, P. Beauverger, and F. Wild. 1992. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73:1703-1707.
5. Buckland, R., and F. Wild. 1989. Leucine zipper motif extends. Nature (London) 338:547.
6. Bull, T. E. 1988. ROESY relaxation theory. J. Magn. Reson. 80:470-481.
7. Caffrey, M., M. Cai, J. Kaufman, S. J. Stahl, P. T. Wingfield, D. G. Covell, A. M. Gronenborn, and G. M. Clore. 1998. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J. 17:4572-4584.
8. Campbell, M. J. 1995. Lipofection reagents prepared by a simple ethanol injection technique. Bio/Technology 18:1027-1032.
9. Chambers, P., C. R. Pringle, and J. J. Easton. 1990. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71:3075-3080.
10. Chan, D. C., D. Fass, J. M. Berger, and P. S. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273.
11. Chan, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Cell 93:681-684.
12. Chang, D. K., S. F. Cheng, and W. J. Chien. 1997. The amino-terminal fusion domain peptide of human immunodeficiency virus type 1 gp41 inserts into the sodium dodecyl sulfate micelle primarily as a helix with a conserved glycine at the micelle-water interface. J. Virol. 71:6593-6602.
13. 1H nuclear magnetic resonance and restrained molecular dynamics. J. Mol. Biol. 186:435-455.
14. Creighton, T. E. 1984. Proteins: structure and molecular properties. W. H. Freeman & Co., New York, N.Y.
15. 1H NMR spectra vis two-dimensional homonuclear Hartmenn-Hahn spectroscopy. J. Am. Chem. Soc. 107:2820-2821.
16. Eich, G., G. Bodenhausen, and R. R. Ernst. 1982. Exploring nuclear spin systems by relayed magnetization transfer. J. Am. Chem. Soc. 104:3731.
17. Furuta, R. A., C. T. Wild, Y. Weng, and C. D. Weiss. 1998. Capture of an early fusion-active conformation of HIV-1 gp41. Nat. Struct. Biol. 5:276-279.
18. Ghosh, J. K., M. Ovadia, and Y. Shai. 1997. A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus. Biochemistry 36:15451-15462.
19. Ghosh, J. K., S. G. Peisajavich, M. Ovadia, and Y. Shai. 1998. Structure-function study a a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion. J. Biol. Chem. 273:27182-27190.
20. Ghosh, J. K., and Y. Shai. 1998. A peptide derived from a conserved domain of Sendai virus fusion protein inhibits virus-cell fusion. J. Biol. Chem. 273: 7252-7259.
21. Gierasch, L. M., J. E. Lacy, K. F. Thompson, A. L. Rockwell, and P. I. Watnick. 1982. Conformations of model peptides in membrane-mimetic environments. Biophys. J. 37:275-284.
22. Gotoh, B., T. Ogasawara, T. Toyoda, N. M. Inocencio, M. Hamaguchi, and Y. Nagai. 1990. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J. 9:4189-4195.
23. Gotoh, B., Y. Ohnishii, N. M. Inocencio, E. Esaki, K. Nakayama, P. J. Barr, G. Thomas, and Y. Nagai. 1992. Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J. Virol. 66:6391-6397.
24. Hernandez, L. D., L. R. Hoffman, T. G. Wolfsberg, and J. M. White. 1996. Virus-cell and cell-cell fusion. Annu. Rev. Cell Biol. 12:627-661.
25. Hicks, R. P., and J. K. Young. 1994. Magnetization transfer via isotropic mixing: an introduction to the HOHAHA experiment. Concepts Magn. Reson. 6:115-130.
26. Joshl, S. B., R. E. Dutch, and R. A. Lamb. 1998. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology 248:20-34.
27. Lamb, R. A. 1993. Paramyxovirus fusion: a hypothesis of changes. Virology 197:1-11.
28. Lamb, R. A., and D. Kolakofsky. 1996. Paramyxoviridae: the viruses and their replication, p. 1177-1206. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
29. Lambert, D. M., S. Barney, A. L. Lambert, K. Guthrie, R. Medinas, D. E. Davis, T. Bucy, J. Erickson, G. Merutka, and S. R. Petteway. 1996. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 93:2186-2191.
30. Li, Z., T. Sergel, E. Razvi, and T. Morrison. 1998. Effect of cleavage mutants on syncytium formation directed by the wild-type fusion protein of Newcastle disease virus. J. Virol. 72:3789-3795.
31. Matthews, T. J., C. Wild, C.-H. Chen, D. P. Bolognesi, and M. L. Greenberg. 1994. Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140:93-104.
32. McDonnell, P. A., and S. J. Opella. 1993. Effect of detergent concentration on multidimensional solution NMR spectra of membrane proteins in micelles. J. Magn. Reson. Ser. B 102:120-125.
33. McDonnell, P. A., K. Shon, Y. Kim, and S. J. Opella. 1993. fd coat protein structure in membrane environments. J. Mol. Biol. 233:447-463.
34. Monck, J. R., and J. M. Fernandez. 1992. The exocytotic fusion pore. J. Cell Biol. 119:1395-1404.
35. 1 of the Newcastle disease virus fusion protein in cleavage and fusion. Virology 193:997-1000.
36. Munoz-Barroso, I., S. Durell, K. Sakaguchi, E. Apella, and R. Blumenthal. 1998. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biol. 140:315-323.
37. Rapaport, D., M. Ovadia, and Y. Shai. 1995. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. EMBO J. 14:5524-5531.
38. Reitter, J., T. Sergel, and T. Morrison. 1995. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J. Virol. 69:5995-6004.
39. Rose, G. D., L. M. Glerasch, and J. A. Smith. 1985. Turns in peptides and proteins. Adv. Protein Chem. 37:1-106.
40. Sergel, T., L. W. McGinnes, M. E. Peeples, and T. G. Morrison. 1993. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 193:717-726.
41. Sergel, T., et al. Unpublished data.
42. Sergel-Germano, T., C. McQuain, and T. Morrison. 1994. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68:7654-7658.
43. States, D. J., R. A. Haberhorn, and D. J. Rubin. 1982. A two dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Reson. 48:286-292.
44. Tan, K., J.-H. Liu, J.-H. Wang, S. Shen, and M. Lu. 1997. Atomic structure of a thermostable subdomain of the HIV-1 gp41. Proc. Natl. Acad. Sci. USA 94:12303-12308.
45. Wiessenhorn, W., A. Dessen, S. C. Harrison, J. J. Skehel, and D. C. Wiley. 1997. Atomic structure of the ectodomain from HIV-1 gp-41. Nature (London) 387:426-430.
46. Wild, C., J. W. Dubay, T. Greenwell, J. T. Baird, T. G. Oas, C. McDanal, E. Hunter, and T. Mathews. 1994. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA 91:12676-12580.
47. Wild, C., T. Oas, C. McDanal, D. Bolognesi, and T. Mathews. 1992. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89:10537-10541.
48. Wild, C. T., D. C. Shugars, T. K. Greenwell, C. B. McDanal, and T. J. Mathews. 1994. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91:9770-9774.
49. Wild, T. F., and R. Buckland. 1997. Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein. J. Gen. Virol. 78:107-111.
50. Wishart, D. S., B. D. Sykes, and F. M. Richards. 1992. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31:1647-1651.
51. Wüthrich, K. 1986. NMR of proteins and nucleic acids. John Wiley & Sons, Inc., New York, N.Y.
52. Wüthrich, K., M. Billeter, and W. Braun. 1984. Polypeptide secondary structure determined by nuclear magnetic resonance observation of short proton-proton distances, J. Mol. Biol. 180:715-740.
53. Yao, Q., and R. W. Compans. 1996. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology 223:103-112.
54. Young, J. K., C. Anklin, and R. P. Hicks. 1994. NMR and molecular modeling investigations of the neuropeptide substance P in the presence of 15 mM sodium dodecyl sulfate micelles. Biopolymers 34:1449-1462.
55. Young, J. K., and R. P. Hicks. 1994. NMR and molecular modeling investigations of the neuropeptide bradykinin in three different solvent systems: DMSO, 9:1 dioxane/water, and in the presence of 7.4 mM lysophosphatidylcholine micelles. Biopolymers 34:611-623.
56. Young, J. K., R. P. Hicks, G. E. Wright, and T. G. Morrison. 1997. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology 238:291-304.